Published in Ophthalmology on January 10, 2006
Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol (2008) 1.70
Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol (2011) 1.41
Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol (2011) 1.38
Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci (2007) 1.17
Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization. Am J Pathol (2011) 1.09
PEDF regulates vascular permeability by a γ-secretase-mediated pathway. PLoS One (2011) 1.05
PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp Eye Res (2008) 1.04
Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients. J Res Med Sci (2012) 1.03
Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis (2007) 1.01
Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression. Invest Ophthalmol Vis Sci (2010) 0.99
Aqueous cytokine and growth factor levels do not reliably reflect those levels found in the vitreous. Mol Vis (2011) 0.97
Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy. Indian J Ophthalmol (2010) 0.97
Pigment epithelium-derived factor secreted from retinal pigment epithelium facilitates apoptotic cell death of iPSC. Sci Rep (2013) 0.93
Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Graefes Arch Clin Exp Ophthalmol (2010) 0.92
Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag (2007) 0.92
Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes. Arch Ophthalmol (2009) 0.90
Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J Biol Chem (2009) 0.90
Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest (2008) 0.89
Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema. Indian J Ophthalmol (2015) 0.86
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol (2012) 0.85
Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy. J Diabetes Metab (2013) 0.85
Intravitreal bevacizumab: an analysis of the evidence. Clin Ophthalmol (2007) 0.84
The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease. Int J Mol Sci (2010) 0.82
Current and future approaches in the prevention and treatment of diabetic retinopathy. Clin Ophthalmol (2008) 0.81
Angiogenesis in diabetes and obesity. Rev Endocr Metab Disord (2015) 0.80
Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol (2009) 0.79
Delayed corneal epithelial healing after intravitreal bevacizumab: a clinical and experimental study. J Ophthalmic Vis Res (2011) 0.78
Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment. Mol Vis (2014) 0.78
Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema. J Ophthalmol (2015) 0.78
Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema. Int Ophthalmol (2013) 0.77
Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema. Jpn J Ophthalmol (2013) 0.76
Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats. Mol Vis (2010) 0.76
Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema. PLoS One (2017) 0.75
Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory. J Diabetes Res (2016) 0.75
Characterization of the human aqueous humour proteome: A comparison of the genders. PLoS One (2017) 0.75
Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy. Oman J Ophthalmol (2011) 0.75
Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration. Invest Ophthalmol Vis Sci (2016) 0.75
GLUT1 activity contributes to the impairment of PEDF secretion by the RPE. Mol Vis (2016) 0.75
Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1. Lab Invest (2015) 0.75
Vitrectomy for center-involved diabetic macular edema. Clin Ophthalmol (2016) 0.75
Comparison of surgical procedures for vitreous surgery in diabetic macular edema. Jpn J Ophthalmol (2009) 0.75
The genome sequence of silkworm, Bombyx mori. DNA Res (2004) 4.27
Ultrafine membrane compartments for molecular diffusion as revealed by single molecule techniques. Biophys J (2004) 3.54
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol (2004) 3.28
Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol (2005) 2.32
Improvement in cognitive impairment after cataract surgery in elderly patients. J Cataract Refract Surg (2004) 2.24
Subconjunctival hemorrhage and conjunctivochalasis. Ophthalmology (2009) 2.20
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol (2002) 2.01
Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2005) 1.95
Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol (2004) 1.92
Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology (2009) 1.91
Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology (2003) 1.83
The long-term effects of self-management education for patients with type 2 diabetes on glycemic control: response to Norris et al. Diabetes Care (2002) 1.78
Effect of perioperative glycemic control in progression of diabetic retinopathy and maculopathy. Arch Ophthalmol (2006) 1.64
Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. Br J Ophthalmol (2010) 1.63
Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Ophthalmologica (2005) 1.59
Recent causes of subconjunctival hemorrhage. Ophthalmologica (2009) 1.58
Adjusting intraocular lens power for sulcus fixation. J Cataract Refract Surg (2003) 1.48
Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology (2009) 1.44
Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study. J Atheroscler Thromb (2015) 1.44
Human corneal endothelial cell precursors isolated by sphere-forming assay. Invest Ophthalmol Vis Sci (2005) 1.43
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol (2002) 1.36
Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol (2003) 1.27
Cup-shaped choroidal excavation detected by optical coherence tomography: a case report. Retin Cases Brief Rep (2010) 1.25
Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology (2008) 1.23
Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology (2005) 1.20
Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata Study. Ophthalmology (2006) 1.17
Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion. Eur J Ophthalmol (2010) 1.16
Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells. Invest Ophthalmol Vis Sci (2006) 1.15
Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol (2005) 1.11
High-dose steroid therapy for idiopathic optic perineuritis: a case series. J Med Case Rep (2010) 1.11
Proteome analysis of human vitreous proteins. Mol Cell Proteomics (2003) 1.11
Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion. Acta Ophthalmol (2010) 1.07
Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J Biol Chem (2005) 1.06
Questionnaire survey on periodic ocular examination in Japanese diabetic patients. Am J Ophthalmol (2003) 1.06
Distribution of precursors in human corneal stromal cells and endothelial cells. Ophthalmology (2007) 1.05
The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem (2010) 1.04
Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine. Diabetes Care (2013) 1.02
Sphere formation and expression of neural proteins by human corneal stromal cells in vitro. Invest Ophthalmol Vis Sci (2005) 1.02
Identification of KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus. Am J Hum Genet (2010) 1.01
Autologous transplantation of conjunctival epithelial cells cultured on amniotic membrane in a rabbit model. Mol Vis (2007) 1.01
Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. Graefes Arch Clin Exp Ophthalmol (2010) 1.00
Corneal stromal and endothelial cell precursors. Cornea (2006) 1.00
Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res (2005) 1.00
Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina (2011) 1.00
Association of inflammatory factors with macular edema in branch retinal vein occlusion. JAMA Ophthalmol (2013) 0.99
Vitreous inflammatory factors in macular edema with central retinal vein occlusion. Jpn J Ophthalmol (2011) 0.98
Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema. Ophthalmology (2007) 0.98
The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucoma. J Ocul Pharmacol Ther (2005) 0.97
Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy. J Cataract Refract Surg (2002) 0.97
Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study. J Inflamm (Lond) (2010) 0.97
Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. J Pharmacol Exp Ther (2010) 0.96
Inflammatory factors in major and macular branch retinal vein occlusion. Ophthalmologica (2012) 0.94
Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery. J Cataract Refract Surg (2008) 0.94
Conjunctivochalasis and contact lenses. Am J Ophthalmol (2009) 0.94
Changes of conjunctivochalasis with age in a hospital-based study. Am J Ophthalmol (2008) 0.94
Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily. Acta Ophthalmol Scand (2003) 0.93
Apparent accommodation and corneal wavefront aberration in pseudophakic eyes. Invest Ophthalmol Vis Sci (2002) 0.93
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Curr Eye Res (2011) 0.93
Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol (2003) 0.93